{"product_id":"fda-pre-submission-q-sub-510k","title":"FDA Pre-Submission (Q-Sub) Package","description":"\u003cp\u003e```html\u003c\/p\u003e\n\u003cstyle\u003e\n  .cn-service-content {\n    color: #000000;\n    font-size: 16px;\n    line-height: 1.75;\n  }\n\n  .cn-service-content h2,\n  .cn-service-content h3,\n  .cn-service-content p,\n  .cn-service-content li,\n  .cn-service-content strong {\n    color: #000000;\n  }\n\n  .cn-service-content h2 {\n    font-size: 25px;\n    line-height: 1.4;\n    margin: 30px 0 14px;\n  }\n\n  .cn-service-content h3 {\n    font-size: 19px;\n    margin: 22px 0 10px;\n  }\n\n  .cn-service-content p {\n    margin: 0 0 16px;\n  }\n\n  .cn-service-content ul,\n  .cn-service-content ol {\n    padding-left: 24px;\n    margin: 0 0 22px;\n  }\n\n  .cn-service-content li {\n    margin-bottom: 9px;\n  }\n\n  .cn-service-content .cn-note {\n    border: 1px solid #dddddd;\n    padding: 18px;\n    margin-top: 24px;\n  }\n\n  @media (max-width: 600px) {\n    .cn-service-content h2 {\n      font-size: 22px;\n    }\n  }\n\u003c\/style\u003e\n\u003cdiv class=\"cn-service-content\"\u003e\n\u003ch2\u003eFDA Pre-Submission (Q-Sub) Package for Medical Devices\u003c\/h2\u003e\n\u003cp\u003ePlanning to submit a medical device to the US Food and Drug Administration (FDA)? Early regulatory feedback can help manufacturers understand FDA's expectations, clarify technical questions, and plan appropriate testing and documentation before making a formal submission.\u003c\/p\u003e\n\u003cp\u003eThe FDA Pre-Submission (Q-Sub) Package from Cosmetic Compliance Nest provides regulatory documentation support to help medical device manufacturers prepare a Pre-Submission request, organise technical questions, and present relevant device information for FDA feedback.\u003c\/p\u003e\n\u003cp\u003eA well-prepared Q-Submission can help identify areas requiring further discussion before a future 510(k), De Novo, PMA, or other applicable regulatory submission. The suitability of the process depends on the device, the questions being asked, and the relevant FDA programme.\u003c\/p\u003e\n\u003ch2\u003eWhat Is an FDA Pre-Submission (Q-Sub)?\u003c\/h2\u003e\n\u003cp\u003eAn FDA Pre-Submission, commonly called a Pre-Sub, is a type of Q-Submission through which a medical device sponsor can request FDA feedback on specific regulatory, scientific, or technical questions before making a planned marketing submission.\u003c\/p\u003e\n\u003cp\u003eDepending on the project, manufacturers may seek feedback on testing strategies, nonclinical study protocols, clinical study design, proposed regulatory pathways, or other issues relevant to the development and evaluation of a medical device.\u003c\/p\u003e\n\u003cp\u003eThe objective is to support a more informed regulatory strategy by giving FDA an opportunity to provide feedback on clearly defined questions. FDA feedback is based on the information provided and does not guarantee the outcome of a later marketing submission.\u003c\/p\u003e\n\u003ch2\u003eWhat Does Our FDA Q-Sub Package Cover?\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInitial Regulatory Assessment:\u003c\/strong\u003e Review the device concept, intended use, development stage, and planned FDA regulatory pathway.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePre-Submission Strategy:\u003c\/strong\u003e Help identify the key issues and questions for which FDA feedback may be useful.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuestion Development:\u003c\/strong\u003e Assist with preparing clear, focused questions supported by relevant background information.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDevice Background Documentation:\u003c\/strong\u003e Organise applicable device descriptions, intended use information, technological characteristics, and development details.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTesting Strategy Discussion:\u003c\/strong\u003e Help document proposed nonclinical or performance testing approaches where relevant to the questions being submitted.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinical and Scientific Questions:\u003c\/strong\u003e Assist with organising applicable questions concerning clinical study planning or scientific evidence, subject to the agreed scope.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQ-Submission Document Preparation:\u003c\/strong\u003e Support preparation and organisation of the applicable Pre-Submission package.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSubmission Readiness Review:\u003c\/strong\u003e Review the draft package for clarity, completeness, and consistency before submission by the responsible sponsor.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe final scope depends on the device, the questions requiring feedback, the available evidence, and the agreed service deliverables. Specialised scientific, statistical, clinical, or laboratory work may require separate support.\u003c\/p\u003e\n\u003ch2\u003eWhen Should You Consider an FDA Pre-Submission?\u003c\/h2\u003e\n\u003cp\u003eA Pre-Submission may be useful when a manufacturer needs to discuss important regulatory or technical questions before investing in further development or preparing a marketing submission.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eUncertain Regulatory Pathway:\u003c\/strong\u003e When you need to discuss a proposed pathway or specific regulatory questions with FDA.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e510(k) Planning:\u003c\/strong\u003e When preparing a Traditional 510(k) and seeking feedback on selected testing or technical issues.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDe Novo Planning:\u003c\/strong\u003e When developing a device for which a De Novo request may be considered and early feedback could help address specific questions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTesting Protocols:\u003c\/strong\u003e When you want to seek feedback on proposed nonclinical testing or validation approaches.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinical Study Planning:\u003c\/strong\u003e When feedback on aspects of a proposed clinical investigation may be helpful.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNovel Technology:\u003c\/strong\u003e When the device incorporates new technology or raises technical questions that may benefit from early regulatory discussion.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eA Q-Submission is not necessary for every medical device project. The decision to request FDA feedback should be based on the specific questions, project stage, and regulatory strategy.\u003c\/p\u003e\n\u003ch2\u003eTypes of Questions That May Be Included\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRegulatory Pathway Questions:\u003c\/strong\u003e Questions about the proposed approach to a future FDA marketing submission.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePerformance Testing:\u003c\/strong\u003e Questions about proposed bench testing, test methods, acceptance criteria, or supporting evidence.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiocompatibility:\u003c\/strong\u003e Questions about the planned biological evaluation approach, where applicable.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSterilisation and Packaging:\u003c\/strong\u003e Questions about proposed validation approaches or supporting evidence, where relevant.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSoftware and Cybersecurity:\u003c\/strong\u003e Questions about relevant software documentation, verification, validation, or cybersecurity considerations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinical Evidence:\u003c\/strong\u003e Questions about proposed clinical investigations, study design, or clinical evidence requirements.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRisk Management:\u003c\/strong\u003e Questions concerning relevant safety risks and the proposed approach to evaluating them.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSubmission Content:\u003c\/strong\u003e Questions about specific documentation or evidence that may be relevant to a planned marketing submission.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eQuestions should be specific and supported by enough background information for FDA to understand the device, the issue being discussed, and the feedback being requested.\u003c\/p\u003e\n\u003ch2\u003eOur FDA Pre-Submission Preparation Process\u003c\/h2\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eInitial Consultation:\u003c\/strong\u003e Review the device, development stage, intended use, and planned regulatory objectives.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuestion Identification:\u003c\/strong\u003e Identify the technical or regulatory issues for which FDA feedback may be beneficial.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBackground Information Review:\u003c\/strong\u003e Review relevant device descriptions, available testing evidence, proposed protocols, and supporting records.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuestion Drafting:\u003c\/strong\u003e Help prepare focused questions and organise the rationale and context for each question.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePackage Preparation:\u003c\/strong\u003e Organise the applicable Q-Submission documentation and supporting information within the agreed scope.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReadiness Review:\u003c\/strong\u003e Check the draft package for clarity, consistency, and completeness against the applicable requirements.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFinalisation:\u003c\/strong\u003e Provide the prepared materials for review and approval by the sponsor or authorised submitter before filing with FDA.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch2\u003eDocuments and Information You May Need\u003c\/h2\u003e\n\u003cp\u003eThe information required depends on the purpose of the Pre-Submission and the questions being asked. Relevant documents may include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDevice name, description, and intended use.\u003c\/li\u003e\n\u003cli\u003eDevice development stage and planned regulatory pathway.\u003c\/li\u003e\n\u003cli\u003eAvailable product specifications, drawings, and technological information.\u003c\/li\u003e\n\u003cli\u003eRelevant predicate or comparable device information, where applicable.\u003c\/li\u003e\n\u003cli\u003eExisting performance testing, verification, and validation data.\u003c\/li\u003e\n\u003cli\u003eProposed testing protocols or study plans requiring FDA feedback.\u003c\/li\u003e\n\u003cli\u003eRisk management documentation, where available and relevant.\u003c\/li\u003e\n\u003cli\u003eApplicable software, biocompatibility, sterilisation, or clinical information.\u003c\/li\u003e\n\u003cli\u003eA list of the specific questions for which FDA feedback is requested.\u003c\/li\u003e\n\u003cli\u003eRelevant previous FDA correspondence, where applicable.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNot all documents are required for every Q-Submission. The package should be proportionate to the questions and the stage of device development.\u003c\/p\u003e\n\u003ch2\u003eWho Can Benefit from This Service?\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eMedical device manufacturers planning an FDA marketing submission.\u003c\/li\u003e\n\u003cli\u003eStart-ups developing new medical technologies.\u003c\/li\u003e\n\u003cli\u003eCompanies preparing for a Traditional 510(k), De Novo, or other applicable regulatory pathway.\u003c\/li\u003e\n\u003cli\u003eManufacturers seeking feedback on proposed testing protocols or technical questions.\u003c\/li\u003e\n\u003cli\u003eRegulatory affairs teams planning discussions with FDA before a formal submission.\u003c\/li\u003e\n\u003cli\u003eDevelopers who need to organise their regulatory questions and supporting documentation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eBenefits of an FDA Pre-Submission Package\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eClearer Regulatory Questions:\u003c\/strong\u003e Organise technical and regulatory questions in a structured format.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEarly Planning:\u003c\/strong\u003e Seek feedback on selected issues before finalising a future marketing submission.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBetter Documentation:\u003c\/strong\u003e Present device background information and the rationale for proposed approaches clearly.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTesting Strategy Support:\u003c\/strong\u003e Prepare focused questions about proposed testing methods or protocols, where relevant.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImproved Team Coordination:\u003c\/strong\u003e Help align regulatory, engineering, clinical, and quality teams around the issues requiring feedback.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMore Informed Decisions:\u003c\/strong\u003e Use applicable FDA feedback as an input to future regulatory planning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eUnderstanding FDA Feedback and Next Steps\u003c\/h2\u003e\n\u003cp\u003eFDA feedback received through a Pre-Submission is intended to inform discussion and planning around the questions raised. The usefulness of that feedback depends on the information provided, the questions asked, and the context of the device.\u003c\/p\u003e\n\u003cp\u003eFeedback does not constitute FDA clearance, approval, or a guarantee that a future submission will be accepted or receive a favourable decision. Manufacturers remain responsible for meeting all applicable requirements and for the content of subsequent submissions.\u003c\/p\u003e\n\u003ch2\u003eFrequently Asked Questions About FDA Pre-Submissions\u003c\/h2\u003e\n\u003cp\u003eVisit our dedicated Frequently Asked Questions page for further information about FDA Q-Submissions, Pre-Submission preparation, technical questions, supporting documentation, and regulatory planning.\u003c\/p\u003e\n\u003ch2\u003eRequest FDA Pre-Submission Support\u003c\/h2\u003e\n\u003cp\u003eDo you need to discuss regulatory or technical questions with FDA before submitting your medical device application? \u003cstrong\u003eCosmetic Compliance Nest\u003c\/strong\u003e can help assess your objectives and prepare a suitable scope for Q-Submission documentation support.\u003c\/p\u003e\n\u003cp\u003eShare your device details, development stage, planned regulatory pathway, and proposed questions to begin the assessment.\u003c\/p\u003e\n\u003cdiv class=\"cn-note\"\u003e\n\u003ch3\u003eImportant Disclaimer\u003c\/h3\u003e\n\u003cp\u003eCosmetic Compliance Nest provides independent regulatory documentation and consultancy services and is not affiliated with or endorsed by the US Food and Drug Administration (FDA). A Pre-Submission is a mechanism for requesting FDA feedback on specific questions and does not guarantee clearance, approval, acceptance of a future submission, or a particular regulatory outcome. FDA feedback is based on the information available during the interaction and should be considered in the context of applicable requirements. The device sponsor remains responsible for the accuracy of the information provided, regulatory decisions, and final submissions. Clinical studies, laboratory testing, specialised scientific assessments, official fees, and other third-party services are excluded unless expressly included in the agreed service scope.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Spectra Cosmetic Compliance","offers":[{"title":"Default Title","offer_id":51539740786855,"sku":null,"price":913504.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0768\/9496\/1831\/files\/laboratory_9.png?v=1792312148","url":"https:\/\/www.cosmeticcompliancenest.com\/products\/fda-pre-submission-q-sub-510k","provider":"Nest Qual","version":"1.0","type":"link"}